Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C3AR1 | Q16581 | 1/20 | 0.47 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.41 |
| ▸ | GNPAT | O15228 | 1/20 | 0.40 |
| ▸ | SHMT1 | P34896 | 1/20 | 0.39 |
| ▸ | ECE1 | P42892 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KLK7 | P49862 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 1/20 | 0.36 |
| ▸ | FNTB | P49356 | 1/20 | 0.36 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.36 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12222096 | 1.00 | C3AR1 (0.47) | C3AR1NOD1CTDSP1FOLH1GNPAT | |
| SCHEMBL11913625 | 1.00 | C3AR1 (0.47) | C3AR1NOD1CTDSP1FOLH1GNPAT | |
| SCHEMBL25148126 | 0.88 | SIRT5 (0.38) | C3AR1NOD1CTDSP1FOLH1ECE1 | |
| SCHEMBL24804881 | 0.88 | C3AR1 (0.49) | C3AR1NOD1CTDSP1FOLH1GNPAT | |
| SCHEMBL29359380 | 0.87 | C3AR1 (0.46) | C3AR1NOD1CTDSP1FOLH1GNPAT | |
| SCHEMBL16862613 | 0.87 | C3AR1 (0.46) | C3AR1NOD1CTDSP1FOLH1GNPAT | |
| SCHEMBL6047671 | 0.87 | C3AR1 (0.46) | C3AR1NOD1CTDSP1FOLH1GNPAT | |
| SCHEMBL28819908 | 0.87 | C3AR1 (0.46) | C3AR1NOD1CTDSP1FOLH1GNPAT | |
| SCHEMBL16862522 | 0.87 | C3AR1 (0.46) | C3AR1NOD1CTDSP1FOLH1GNPAT | |
| SCHEMBL16801786 | 0.87 | C3AR1 (0.46) | C3AR1NOD1CTDSP1FOLH1GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230271999-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | INVOX PHARMA LIMITED (GB) | 2023-08-31 | — | — | US | disclosed |
| US-11707531-B2 | Compounds, compositions, and methods for the treatment of disease | F-star Therapeutics, Inc. (GB) | 2023-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271999-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | STING1, MAVS, IRF3 | C3AR1 696/4885NOD1 90/4885CTDSP1 2450/4885 |
| US-11707531-B2 | Compounds, compositions, and methods for the treatment of disease | STING1, MAVS, IRF3 | C3AR1 696/4885NOD1 90/4885CTDSP1 2450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.